Kritoma

Discovery

Explore Topics Papers

Docs Terms Privacy

Search Kritoma

Recent searches

Searches you run from this bar will appear here.

GLP-1 receptor agonists for obesity treatment

Clinical MedicineUpdated Oct 5, 2026Version v1

Knowledge Timeline Gaps (1)Evidence (359)Community (0)

Evidence

Public papers linked to this topic and used as evidence for gaps, timelines, and knowledge views.

359 papers

SearchSort evidence

All359 Core251 Supporting111 Background0

Showing 289-300 of total 359 evidence records.

Open a paper to inspect abstract, source links, and topic context.

2026PubMedSupporting evidence

Use of glucagon-like peptide-1 receptor agonists is associated with inadequate bowel preparation for colonoscopy in patients with diabetes.

Ogawa O

Jan 1, 2026

Journal of diabetes investigation

2026PubMedDirectly related

Glucagon-like receptor-1 agonists and impotence: A meta-analysis.

Mirghani HO; AlQurashi AM

Jan 1, 2026World journal of methodology

2026PubMedDirectly related

GLP-1 receptor agonist therapy is associated with increased symptomatic remission in ulcerative colitis: a matched cohort study.

Alqinai B; Gayam S; Hadam-Veverka J

Jan 1, 2026Inflammatory bowel diseases

2026PubMedDirectly related

GLP-1 receptor agonist therapy and skeletal muscle: A narrative review synthesizing adult evidence with implications for older adults.

Jagasia K; Pfeiffer AM; Vitale K

Jan 1, 2026JAR life

2026PubMedDirectly related

The effect of sex and endurance exercise training on the incretin signaling pathway in 17 rat tissues.

Jin C; Many G; Reynoso Spurrier CS; Borsellino P; Wheeler MT; Adkins JN; Snyder MP; Newgard CB; Radom-Aizik S; Cooper DM; Bodine SC; Schenk S; Lindholm ME

Jan 1, 2026Physiological genomics

2026PubMedDirectly related

Psychiatric and eye disorders associated with use of glucagon-like peptide 1 receptor agonists (GLP-1 RAs).

Ammendolia I; Mondello C; Esposito E; Calapai G; Currò M; Midiri P; Firenzuoli B; Noto A; Cancellieri A; Cardia L; Ardizzone A; Calapai F

Jan 1, 2026Naunyn-Schmiedeberg's archives of pharmacology

2026PubMedDirectly related

Exploring The Role of GLP-1 Receptor Agonists and DPP4 Inhibitors in the Treatment of Opioid Use Disorder: A Scoping Review.

Baldwin K; Lau A; Ignaszewski MJ; Wong JSH; Azar P; Siu JTP

Jan 1, 2026Journal of dual diagnosis

2026PubMedDirectly related

Risk of protein intake deficiency during treatment with GLP-1 and GIP/GLP-1 receptor agonists: considerations for secondary sarcopenia.

Prokopidis K; Cacciatore S; Anton SD; Batsis JA

Jan 1, 2026Advances in therapy

2026PubMedDirectly related

Adult Overweight and Obesity Management: Updates From the 2025 U.S. Department of Veterans Affairs and U.S. Department of Defense Clinical Practice Guidelines.

Corrado RL; Raffa SD; Bauer EM; Eisenberg D; Weare-Regales N; Antonovich N; Loblack A; Berdiel E; Kelber MS; Klimovich J; Magee JS; Sall J; Mayer SB

Jan 1, 2026Annals of internal medicine

2026PubMedDirectly related

GLP-1 receptor agonists and outcomes after cervical spine fusion: a systematic review, meta-analysis, and evidence map of real-world evidence.

Yu X; Wang S; Lin K; Guan J

Jan 1, 2026European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society

2026PubMedDirectly related

Dual-transporter-targeted oral nanomicelles of semaglutide enable enhanced intestinal absorption and metabolic reprogramming in obesity and diabetes.

Subedi L; Bamjan AD; Kim E; Phuyal S; Sapkota B; Kim KT; Cho SS; Shim JH; Seo JB; Park JW

Jan 1, 2026Journal of controlled release : official journal of the Controlled Release Society

2026PubMedSupporting evidence

Blood Pressure Reduction Time Windows in Stroke: A Systematic Review and Network Meta-Analysis.

Yu X; Shi C; Wang W; Xue D; Jiang Y; Zhao M

Jan 1, 2026Brain and behavior

Page 25 of 30Showing 289-300 of total 359 results.

1...242526...30

GLP-1 receptor agonists for obesity treatment — Research Evidence and Topic... | Kritoma